Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Borer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Circulation|June 20, 2003
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003Jeffrey Borer, Paul Armstrong,
Circulation|May 9, 2002
Losartan potassium (Cozaar)JoAnn Lindenfeld, Jeffrey Borer, Paul W Armstrong
Circulation|August 7, 2002
CandesartanPaul W Armstrong, Beverly H Lorell, Steven Nissen, et al.
Circulation|August 22, 2002
Pravastatin and AspirinPaul W Armstrong, Beverly H Lorell, Steven Nissen, et al.
Circulation|August 22, 2002
OmapatrilatPaul W Armstrong, Beverly H Lorell, Steven Nissen, et al.
Journal of the American College of Cardiology|May 24, 2012
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) studyKarl Swedberg, Michel Komajda, Michael Böhm, et al.
Fundamental & Clinical Pharmacology|August 12, 2010
Surrogate endpoints in randomized cardiovascular clinical trialsMichael Domanski, Stuart Pocock, Corine Bernaud, et al.
European Journal of Heart Failure|August 16, 2012
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failureMichel Komajda, Michael Böhm, Jeffrey Borer, et al.
European Journal of Heart Failure|May 23, 2013
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failureJan-Christian Reil, Michele Robertson, Ian Ford, et al.
European Journal of Heart Failure|June 20, 2017
Heart rate and its reduction in chronic heart failure and beyondAleksandra Nikolovska Vukadinović, Davor Vukadinović, Jeffrey Borer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Circulation|June 20, 2003
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003Jeffrey Borer, Paul Armstrong,
Circulation|May 9, 2002
Losartan potassium (Cozaar)JoAnn Lindenfeld, Jeffrey Borer, Paul W Armstrong
Circulation|August 7, 2002
CandesartanPaul W Armstrong, Beverly H Lorell, Steven Nissen, et al.
Circulation|August 22, 2002
Pravastatin and AspirinPaul W Armstrong, Beverly H Lorell, Steven Nissen, et al.
Circulation|August 22, 2002
OmapatrilatPaul W Armstrong, Beverly H Lorell, Steven Nissen, et al.
Journal of the American College of Cardiology|May 24, 2012
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) studyKarl Swedberg, Michel Komajda, Michael Böhm, et al.
Fundamental & Clinical Pharmacology|August 12, 2010
Surrogate endpoints in randomized cardiovascular clinical trialsMichael Domanski, Stuart Pocock, Corine Bernaud, et al.
European Journal of Heart Failure|August 16, 2012
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failureMichel Komajda, Michael Böhm, Jeffrey Borer, et al.
European Journal of Heart Failure|May 23, 2013
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failureJan-Christian Reil, Michele Robertson, Ian Ford, et al.
European Journal of Heart Failure|June 20, 2017
Heart rate and its reduction in chronic heart failure and beyondAleksandra Nikolovska Vukadinović, Davor Vukadinović, Jeffrey Borer, et al.
Pageof 2